Опыт Ð¿Ñ€Ð¸Ð¼ÐµÐ½ÐµÐ½Ð¸Ñ ÐºÑ€Ð¸Ð¾ÐºÐ¾Ð½Ñервированной плаценты в лечении фетоплацентарной недоÑтаточноÑти и гипокÑии плода
The data about accumulated experience in application of cryopreserved placenta in obstetrics, aimed to treating fetoplacental failure (FPF) and chronic fetal hypoxia (CFH) are shown. The effect mechanism of cryopreserved placenta is based on the effect of metabolically active substances of placental...
Gespeichert in:
| Datum: | 2006 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Publishing House ‘Akademperiodyka’ of the National Academy of Sciences of Ukraine; Institute for Problems of Cryobiology and Cryomedicine
2006
|
| Schlagworte: | |
| Online Zugang: | https://cryo.org.ua/journal/index.php/probl-cryobiol-cryomed/article/view/605 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Назва журналу: | Problems of Cryobiology and Cryomedicine |
Institution
Problems of Cryobiology and Cryomedicine| Zusammenfassung: | The data about accumulated experience in application of cryopreserved placenta in obstetrics, aimed to treating fetoplacental failure (FPF) and chronic fetal hypoxia (CFH) are shown. The effect mechanism of cryopreserved placenta is based on the effect of metabolically active substances of placental origin on different organs and systems of an organism. The implantation of cryopreserved placenta fragment (CPF) considerably improves placenta echostructure of a recipient, enriches uterus-fetus-placenta blood flow due to remodulating placental vessel channel, results in blood redistribution in placental structures, normalises a synthesis of placental proteins in pregnant woman’s organism. The introduction in FPF and CFH therapy protocol of subcutaneous CPF implantation augments the treatment efficiency for this pathology, favourably affects the labour outcome. |
|---|